Back to all AI Solutions
Lunit INSIGHT MMG
Lunit INSIGHT MMG generates (1) the location of breast cancer in the form of heatmaps and/or contour maps, (2) an abnormality score reflecting the probability of the existence of breast cancer, and (3) assessment of breast density.
*assessment of breast density has not been FDA cleared, only CE marked.
Key benefits
- 88% reduction of false-positive recalls
- Early detection of T1 and node-negative breast cancer with 91% and 87% accuracy, respectively
- Improved diagnostic accuracy for dense breasts by up to 9%
Details
- Regulatory:
CE
FDA
MMG
Breast
Oncology
Gynecology
Senology
UKCA
TGA
- Clinical Applications:
CE
FDA
MMG
Breast
Oncology
Gynecology
Senology
UKCA
TGA
- Modality:
CE
FDA
MMG
Breast
Oncology
Gynecology
Senology
UKCA
TGA
- Body Part:
CE
FDA
MMG
Breast
Oncology
Gynecology
Senology
UKCA
TGA
Peer-reviewed publications
Discover the power of AI for your studies
Schedule a demo today
